Trials

Registerstudie Protonenradiotherapie bei Lymphomen

PACE-LUNG

DESTINY-Lung04 (AstraZeneca)

nNGM

PECa-Org Studie

Hi-STEP1

Opposite II: REDESIGN

SoraTram

MSC Imaging

PALUGA

HypoFocal SBRT

Novartis DFV890

EORTC QoL FinTox

IMA402 (bispecific T cell engaging receptor molecule)

Poly-CR-P

HEROES-AYA

ANTELOPE

EORTC QoL RareCancer

INTRINSIC (WO42758)

COMPASS - Studie